Publication: 2773

Publication: 2773

Phase I/II Trial of Temsirolimus and Sorafenib in Treatment of Patients with Recurrent Glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Cancer vol 124 (7) 1455-1463

Year:: 2018
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 7

Parents:: 70 71 501 575 953
Children:: None

Program:: OGC
Primary Committee:: Neuro-Onc
Sec. Committees:

Pharmas:: Pfizer, Bayer
Grants:: U10CA0225224, U10CA180821, U10CA180882, UG1CA189863

Corr. Author:
Authors:: David Schiff Kurt A Jaeckle S. Keith Anderson Evanthia Galanis Caterina Giannini Jan C. Buckner Phillip Stella Patrick J Flynn Bradley J Erickson John F Schwerkoske Vesna Kaluza Erin Twohy Janet Dancey John Wright Jann N. Sarkaria

Networks:: LAPS-MN026, MCRC, METROMIN, MI005, MN017, VA009

Study: NCCTG-N0572
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 1/2

Keywords: